Alexandra Toohey
Baker Bros. Advisors Lp
Assets Managed
$17.416B
Holdings
84
Last Quarter
2026 - Q1
Filed Date
1mo 10d ago
Growth Rate
1.98%(2Q avg: 12.7%)
Sustained Growth
4 quarters
Portfolio positions
This chart displays the top 10 holdings in Baker Bros. Advisors Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 84 positions.
Assets under management
The assets under management (AUM) of Baker Bros. Advisors Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 17.416B in assets, with a quarterly growth rate of 1.98% and a 2-quarter average growth rate of 12.7%. The portfolio is managed by Alexandra Toohey, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
INCY Incyte Corp
| 16.62% | $2.894B 30.744M shares@ $94.12 avg price | Increased 0.01% |
BGNE Beigene Ltd-adr
| 15.01% | $2.613B 8.799M shares@ $296.97 avg price | |
INSM Insmed Inc
| 6.97% | $1.214B 7.421M shares@ $163.53 avg price | Increased 12.57% |
MDGL Madrigal Pharmaceuticals Inc
| 6.44% | $1.121B 2.142M shares@ $523.47 avg price | |
ACAD Acadia Pharmaceuticals Inc
| 5.49% | $954.88M 42.897M shares@ $22.26 avg price | |
RVMD Revolution Medicines Inc
| 5.34% | $929.258M 9.555M shares@ $97.25 avg price | Increased 1.06% |
CELC Celcuity Inc
| 5.19% | $903.508M 7.916M shares@ $114.15 avg price | |
KOD Kodiak Sciences Inc
| 4.36% | $759.319M 19.919M shares@ $38.12 avg price | |
KYMR Kymera Therapeutics Inc
| 4.15% | $721.062M 8.657M shares@ $83.29 avg price | |
SMMT Summit Therapeutics Inc
| 3.97% | $689.975M 36.391M shares@ $18.96 avg price |
1-10 of 84